KARD: Late-stage cardiovascular pipeline advances with adaptive trials and digital health integration
A cardiovascular platform company presented its late-stage pipeline targeting major heart diseases, leveraging adaptive trial designs and digital health tools for faster, more precise development. Key programs include danicamtiv for genetic DCM and ataciguat for aortic stenosis, both advancing thro…